Celyad Oncology SA · EURONEXT:CYAD

Celyad Oncology SA — Fact Sheet (March 2021)

1 slide from Celyad Oncology SA's fact sheet, March 2021

  1. Slide 1: Allogeneic Non Gene-Edited shRNA Platform

    Allogeneic Non Gene-Edited shRNA Platform The ability to control gene expression and optimize function of CAR T cells is essential in order to expand application of CAR T therapies to a wider range of cancers. Short hairpin RNA (shRNA) is a small piece of RNA that can decrease gene expression, effec

Celyad Oncology — Fact Sheet (March 2021) on 6ix